GALLERY 15 PHOTOS| Karsten Strauss, Forbes Staff Shutterstock Employee ate too much birthday cake
Newer GLP-1 medications in development, including triple agonists that target GLP-1, GIP, and glucagon receptors, may offer even broader metabolic and anti-inflammatory effects
GLP-1 RAs can also cause changes in the size of the lips, cheeks, and chin that disrupt the balance of facial features
Who should not take GLP-1 drugs
Comparacin con la versin inyectada La semaglutida inyectada, comercializada como Wegovy, ha demostrado ser una opcin exitosa para la prdida de peso
Physicians should observe for these adverse effects, notably in patients with comorbidities or polypharmacology